Show simple item record

Authordc.contributor.authorSchiattino, Irene 
Authordc.contributor.authorVillegas Ríos, Rodrigo es_CL
Authordc.contributor.authorCruzat, Andrea es_CL
Authordc.contributor.authorCuenca, Jimena es_CL
Authordc.contributor.authorSalazar, Lorena es_CL
Authordc.contributor.authorAravena, Octavio es_CL
Authordc.contributor.authorPesce Reyes, Bárbara es_CL
Authordc.contributor.authorCatalán Martina, Diego es_CL
Authordc.contributor.authorLlanos, Carolina es_CL
Authordc.contributor.authorCuchacovich Turteltaub, Miguel es_CL
Authordc.contributor.authorAguillón Gutiérrez, Juan Carlos es_CL
Admission datedc.date.accessioned2007-05-31T15:01:08Z
Available datedc.date.available2007-05-31T15:01:08Z
Publication datedc.date.issued2005
Cita de ítemdc.identifier.citationBiol Res 38: 7-12, 2005en
Identifierdc.identifier.issn0716-9760
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/127243
General notedc.descriptionArtículo de publicación SciELO
Abstractdc.description.abstractLongitudinal studies aimed at evaluating patients clinical response to specific therapeutic treatments are frequently summarized in incomplete datasets due to missing data. Multivariate statistical procedures use only complete cases, deleting any case with missing data. MI and MIANALYZE procedures of the SAS software perform multiple imputations based on the Markov Chain Monte Carlo method to replace each missing value with a plausible value and to evaluate the efficiency of such missing data treatment. The objective of this work was to compare the evaluation of differences in the increase of serum TNF concentrations depending on the -308 TNF promoter genotype of rheumatoid arthritis (RA) patients receiving anti-TNF therapy with and without multiple imputations of missing data based on mixed models for repeated measures. Our results indicate that the relative efficiency of our multiple imputation model is greater than 98% and that the related inference was significant (p-value < 0.001). We established that under both approaches serum TNF levels in RA patients bearing the G/A -308 TNF promoter genotype displayed a significantly (p-value < 0.0001) increased ability to produce TNF over time than the G/G patient group, as they received successively doses of anti-TNF therapy.en
Lenguagedc.language.isoenen
Publisherdc.publisherSociedad de Biología de Chileen
Keywordsdc.subjectmultiple imputationen
Títulodc.titleMultiple imputation procedures allow the rescue of missing data: An application to determine serum tumor necrosis factor (TNF) concentration values during the treatment of rheumatoid arthritis patients with anti-TNF therapyen
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record